Diagnosis and management of early lung cancer Article Report uri icon

Overview

MeSH Major

  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

abstract

  • Bronchogenic carcinoma remains the leading cause of cancer deaths in the United States. Approximately 80% of newly diagnosed cases are non-small cell lung cancer (NSCLC); 80% of these present with disseminated or locally advanced disease. Unfortunately, only 10% are potentially surgically curable patients with early-stage disease (T1N0/T2N0). Most patients with early-stage disease are asymptomatic, with their lung cancer detected as a result of non-cancer related procedures. Studies have shown that chest radiography as a screening modality resulted in a higher discovery of early disease, but did not translate to a significant reduction in lung cancer mortality. Recent work on low-dose helical CT, however, has renewed interest in the challenge of detecting early-stage lung cancer.

publication date

  • June 2002

Research

keywords

  • Report

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0039-6109(02)00018-X

PubMed ID

  • 12371580

Additional Document Info

start page

  • 457

end page

  • 76, v

volume

  • 82

number

  • 3